Seres Therapeutics announced it will present preclinical data for SER-428, an investigational oral liquid live biotherapeutic designed to reduce bloodstream infections in critically ill patients, at IDWeek 2026. SER-428 targets the gastrointestinal tract to prevent pathogen colonization and is formulated for patients unable to take capsules, including those on feeding tubes. Preclinical studies showed SER-428 significantly reduced harmful bacteria, supporting its potential to lower infection risks and antimicrobial resistance. Seres plans a Phase 1b trial in high-risk ICU patients, pending funding, to further evaluate SER-428's safety and efficacy.
Seres Therapeutics' investigational live biotherapeutic SER-428 is the focus here, with Pluang market data providing context. Among 150 priced Health-sector US stocks tradable on Pluang, 93 rose and 47 fell as of Oct 15, 2026 17:42 WIB. Notably, Inovio Pharmaceuticals Inc (INO) surged 19.68% to USD 1.18 with a typical hold time of 43 days and a 97% buy order activity, contrasting with Enveric Biosciences Inc (ENVB) which dropped 12.41% to USD 1.20 and a shorter hold time of 14 days, while Abeona Therapeutics Inc (ABEO) gained 11.24% to USD 4.85 with a balanced sell/buy order activity.
The Saudi Arabia Non-Invasive Prenatal Testing (NIPT) market is projected to grow from $52.5 million in 2025 to $162.16 million by 2034, at a CAGR of 13.35%. Growth is fueled by rising maternal age, advances in molecular diagnostics, and increased he...
TiDB, powered by PingCAP, announced new cloud platform capabilities to support enterprise and AI applications on a unified data foundation. Key updates include the upcoming general availability of TiDB Cloud Premium, public previews of Bring Your Own...
Alcoa will release its Q3 2026 earnings on October 15, with analysts divided on earnings per share and revenue forecasts due to factors like rising aluminum sales, inventory changes, and higher input costs. The company expects a 54.9% jump in aluminu...
Nokia has transferred 2,142,361 of its own shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was made without compensation and is part of fulfilling commitments u...
Pallavi Mahajan, a senior manager at Nokia Corporation, received 35,192 shares through a share-based incentive on October 15, 2026. This transaction was reported under EU Market Abuse Regulation, reflecting Nokia's ongoing use of equity incentives to...
